PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle Summary Sep 15, 2010	New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples South San Francisco, Calif.--- PRNewswire ---Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, announced that initial	View HTML New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples 14.2 KB
Toggle Summary Jun 9, 2010	Veracyte Completes $28 Million Series B Round – One Step Closer to Commercializing First Molecular Diagnostic Product Veracyte Completes $28 Million Series B Round – One Step Closer to Commercializing First Molecular Diagnostic Product SOUTH SAN FRANCISCO, Calif.--- BUSINESS WIRE ---Veracyte, Inc. announced today the successful completion of its Series B round, a key milestone toward the company’s first product	View HTML Veracyte Completes $28 Million Series B Round – One Step Closer to Commercializing First Molecular Diagnostic Product 10.3 KB